2025 Cure GM1 Impact Report
2025 Cure GM1 Impact Report Check out what you helped us accomplish in 2025 All…
-
-
-
-
-
GM1 Research: Cure GM1 Invests $400,000 to Advance Development of Enzyme Replacement Therapy
Cure GM1 is dedicated to investing in research, seeding new projects, and to the development of multiple treatment modalities for GM1 gangliosidosis. In collaboration with our advisors and consultants, who have decades of experience in biotech and research, Cure GM1 has selected a contract research organization (CRO) to further the development of enzyme replacement therapy (ERT).
-
2024 Cure GM1 Impact Report
Our summary of impact in 2024 is now available to read. Although this year was hard with…
-
2023 Cure GM1 Impact Report – Annual Update And Beyond
Our summary of impact in 2023 is now available to read. After some time reflecting, everyone…
-
Cure GM1 to Collaborate with xCURES for Natural History Study Pilot
Cure GM1, a 501(c)(3) nonprofit organization located in Albany, CA, USA is proud to announce…
-
Over $461K Grant toward Enzyme Replacement Therapy with TEGA Therapeutics
TEGA Therapeutics, Inc. has been awarded a Phase I Small Business and Innovative Research (SBIR)…
